| DiaSorin S.p.A.. (4/11/21). "Press Release: DiaSorin to Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion". Saluggia. |
2021-04-11 |
| Hologic, Inc.. (4/8/21). "Press Release: Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million". Marlborough, MA. |
2021-04-08 |
| Delta 4 GmbH. (4/7/21). "Press Release: Delta 4 Announces Closing of Multi-million Series A Financing Round". Vienna. |
2021-04-07 |
| Metagenomi Inc.. (4/7/21). "Press Release: Metagenomi Extends Series A Financing from RA Capital and Welcomes Andrew Levin to Its Board of Directors". Emeryville, CA. |
2021-04-07 |
| Metrion Biosciences Ltd.. (4/6/21). "Press Release: Metrion Biosciences Closes £2.7m New Equity Financing. Financing Led by Gresham House Ventures". Cambridge. |
2021-04-06 |
| Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London. |
2021-04-06 |
| Drägerwerk AG & Co. KGaA. (4/1/21). "Press Release: Dräger Acquires Majority Share of Swiss Medical Technology Start-up STIMIT". Lübeck. |
2021-04-01 |
| Rentschler Biopharma SE. (3/31/21). "Press Release: Rentschler Biopharma Appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation". Laupheim & Milford, MA. |
2021-03-31 |
| Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London. |
2021-03-30 |
| Pyxis Oncology. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA. |
2021-03-30 |
| Inbrain Neuroelectronics S.L.. (3/26/21). "Press Release: Inbrain Neuroelectronics Raises Over €14M Series A". Barcelona. |
2021-03-26 |
| Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde. |
2021-03-25 |
| Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams |
2021-03-25 |
| Immunai. (3/25/21). "Press Release: Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery Capabilities". New York, NY. |
2021-03-25 |
| Immuneering Corporation. (3/25/21). "Press Release: Immuneering Expands Leadership Team with Appointment of Carolina Garcia Rizo, Ph.D., MBA, as Chief Business Officer". Cambridge, MA. |
2021-03-25 |
| Step Pharma S.A.S.. (3/24/21). "Press Release: Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies". Archamps. |
2021-03-24 |
| PhoreMost Ltd.. (3/23/21). "Press Release: PhoreMost Closes £33M ($46M) Series B Financing". Cambridge. |
2021-03-23 |
| Dunad Therapeutics. (3/23/21). "Press Release: Dunad Therapeutics Emerges to Develop Next-generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology". Cambridge. |
2021-03-23 |
| Meatable. (3/23/21). "Press Release: Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef". |
2021-03-23 |
| Auro Biosciences, Inc.. (3/22/21). "Press Release: Aura Biosciences Announces Oversubscribed $80 Million Financing". Cambridge, MA. |
2021-03-22 |
| Dotmatics Ltd.. (3/22/21). "Press Release: Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company". Bishop’s Stortford & San Diego, CA. |
2021-03-22 |
| Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. |
2021-03-17 |
| ExeVir Bio B.V.. (3/16/21). "Press Release: ExeVir Announces Close of $50 Million / EUR42 million Series A Financing". Belgium. |
2021-03-16 |
| Alchemab Therapeutics Ltd.. (3/16/21). "Press Release: Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s disease". London. |
2021-03-16 |
| CytoSeek Ltd.. (3/16/21). "Press Release: CytoSeek Raises £3.57M ($5M) to Advance Its Mission to Develop the Next Generation of Cell Therapies for Cancer". Bristol. |
2021-03-16 |
| Roche. (3/15/21). "Press Release: Roche Signs Definitive Merger Agreement with GenMark Diagnostics, Inc., to Access Novel Technology to Test for Broad Range of Pathogens with One Patient Sample". Basel. |
2021-03-15 |
| Cellink AB. (3/12/21). "Press Release: Cellink AB (publ) Announces the Completion of the Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Overall Amount of SEK 3.0 Billion [NOT FOR US, CA, AU, |
2021-03-12 |
| Monte Rosa Therapeutics. (3/12/21). "Press Release: Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform". Boston, MA. |
2021-03-12 |
| Touchlight Genetics Ltd.. (3/11/21). "Press Release: Touchlight Raises £42 Million ($58 Million) to Meet Unprecedented Global DNA Demand". Hampton. |
2021-03-11 |
| Cellink AB. (3/11/21). "Press Release: Cellink AB Announces an Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Expected Amount of SEK 2.75 Billion [NOT FOR US, CA, et al.]". Gothenburg. |
2021-03-11 |
| Cellink AB. (3/10/21). "Press Release: Cellink Has Entered into an Agreement to Acquire MatTek, the Global Leader in In-vitro Technology and Alternative Drug Testing Models". |
2021-03-10 |
| AgomAb Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent. |
2021-03-10 |
| BellaSeno GmbH. (3/10/21). "Press Release: BellaSeno and Fraunhofer Institute for Production Technology IPT Receive EUR 1.4 Million BMBF Grant". Leipzig & Aachen. |
2021-03-10 |
| BioPhero ApS. (3/9/21). "Press Release: BioPhero Announces $17 Million Series A For Sustainable Pest Control". Copenhagen. |
2021-03-09 |
| Ventyx Biosciences, Inc.. (3/9/21). "Press Release: Ventyx Biosciences Raises $114 Million Financing Led by VenBio Partners to Advance Diverse Pipeline of Immunology Programs". Encinitas, CA. |
2021-03-09 |
| Pathios Therapeutics Ltd.. (3/8/21). "Press Release: Pathios Therapeutics Boosted by Award of Significant Innovate UK Funding". Oxford. |
2021-03-08 |
| Mikrogen GmbH. (3/8/21). "Press Release: Mikrogen Acquires Lophius Biosciences to Expand into T Cell-Based Testing Market". Neuried & Regensburg. |
2021-03-08 |
| Exscientia Ltd.. (3/4/21). "Press Release: Exscientia Completes $100 Million Series C Financing Round with BlackRock Funds". |
2021-03-04 |
| Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. |
2021-03-03 |
| Atai Life Sciences AG. (3/3/21). "Press Release: Atai Life Sciences Announces the Closing of Its $157 Million Series D Financing Round". New York, NY. |
2021-03-03 |
| Osborne Clarke. (3/2/21). "Press Release: Osborne Clarke Advises Oxular on Its £27M Financing". |
2021-03-02 |
| Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford. |
2021-03-02 |
| ActiTrexx GmbH. (3/2/21). "Press Release: Newly Founded Biotech Company ActiTrexx Receives Funding of € 3.5 Million to Develop Cell Therapy against Transplant Rejection". Mainz. |
2021-03-02 |
| EG 427. (3/1/21). "Press Release: EG 427 Announces €12 Million Series A Financing to Advance Its HSV-1 based Gene Therapy
David Lamond and Stephane Boissel join the company’s board of Directors". Paris. |
2021-03-01 |
| Cellink AB. (3/1/21). "Press Release: Cellink Completes the Acquisition of Ginolis Oy". |
2021-03-01 |
| Achilles Therapeutics plc. (3/1/21). "Press Release: Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States". London. |
2021-03-01 |
| Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. |
2021-03-01 |
| Hologic, Inc.. (3/1/21). "Press Release: Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million". Marlborough, MA. |
2021-03-01 |
| Roivant Sciences GmbH. (2/26/21). "Press Release: Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics". New York, NY, Boston, MA & Basel. |
2021-02-26 |
| Osborne Clarke. (2/25/21). "Press Release: Osborne Clarke Advised Delphi Genetics on Its Acquisition by Catalent". |
2021-02-25 |
| 10x Genomics Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. |
2021-02-24 |
| Vividion Therapeutics, Inc.. (2/24/21). "Press Release: Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs". San Diego, CA. |
2021-02-24 |
| Catalent. (2/23/21). "Press Release: Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities". Somerset, NJ & Gosselies. |
2021-02-23 |
| Mosa Meat B.V.. (2/23/21). "Press Release: Mosa Meat Completes $85m Series B Investment Round". Maastricht. |
2021-02-23 |
| Newcells Biotech Ltd.. (2/23/21). "Press Release: Newcells Biotech Secures Over £5m for 3D Tissue Models". |
2021-02-23 |
| Novo Holdings A/S. (2/22/21). "Press Release: Novo Holdings to Acquire Altasciences". Copenhagen. |
2021-02-22 |
| Teon Therapeutics. (2/22/21). "Press Release: Teon Therapeutics Completes $30 Million Series A Financing". San Francisco, CA. |
2021-02-22 |
| Evox Therapeutics Ltd.. (2/18/21). "Press Release: Evox Therapeutics Completes £69.2 Million Series C Financing". |
2021-02-18 |
| Charles River Laboratories International, Inc.. (2/17/21). "Press Release: Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development". Wilmington, MA. |
2021-02-17 |
| Cellink AB. (2/15/21). "Press Release: Cellink Has Entered into an Agreement to Acquire the Advanced Robotics and Diagnostics Automation Company Ginolis". |
2021-02-15 |
| EnginZyme AB. (2/11/21). "Press Release: EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden". Stockholm. |
2021-02-11 |
| Immunai. (2/11/21). "Press Release: Immunai Raises $60M to Reprogram Immunity". New York, NY. |
2021-02-11 |
| Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam. |
2021-02-10 |
| Evaxion Biotech A/S. (2/10/21). "Press Release: Evaxion Biotech Closes Its U.S. Initial Public Offering of American Depositary Shares". Copenhagen. |
2021-02-10 |
| SpyBiotech Ltd.. (2/10/21). "Press Release: SpyBiotech Raises $32.5M in Series A funding and Appoints Lutz B. Giebel as Chairman". Oxford. |
2021-02-10 |
| Pan Cancer T B.V.. (2/8/21). "Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center". |
2021-02-08 |
| V-Bio Ventures. (2/4/21). "Press Release: First Closing of V-Bio Fund 2 Is Announced at EUR 78 Million". Ghent. |
2021-02-04 |
| Evaxion Biotech A/S. (2/4/21). "Press Release: Evaxion Biotech Announces Pricing of Initial Public Offering". Copenhagen. |
2021-02-04 |
| Scienion AG. (2/3/21). "Press Release: Scienion Continues to Grow and Will Build New Headquarters in Berlin Adlershof". Berlin. |
2021-02-03 |
| Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. |
2021-02-03 |
| Jazz Pharmaceuticals plc. (2/3/21). "Press Release: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader". Dublin & London. |
2021-02-03 |
| Wacker Chemie AG. (2/3/21). "Press Release: Wacker Strengthens Biologics Business by Acquiring US-based Plasmid DNA Manufacturer Genopis". Munich & San Diego, CA. |
2021-02-03 |
| Cytiva. (2/1/21). "Press Release: Cytiva Acquires Vanrx Pharmasystems, Canadian Aseptic Filling Innovator". Amersham. |
2021-02-01 |
| Aber Instruments. (2/1/21). "Press Release: Aber Instruments Acquires BugLab to Consolidate its World-leading Biomass Monitoring Portfolio". Alexandria, VA. |
2021-02-01 |
| BiondVax Pharmaceuticals Ltd.. (1/29/21). "Press Release: BiondVax Announces Pricing of $12.1 Million Follow-on Underwritten Offering of American Depositary Shares". Jerusalem. |
2021-01-29 |
| BiondVax Pharmaceuticals Ltd.. (1/28/21). "Press Release: BiondVax Announces Launch of Proposed Underwritten Follow-on Offering of American Depositary Shares". Jerusalem. |
2021-01-28 |
| Enthera S.r.l.. (1/28/21). "Press Release: Enthera Pharmaceuticals Extends Series A Financing, Raising a Total of €35 million". Milan. |
2021-01-28 |
| CureVac N.V.. (1/28/21). "Press Release: CureVac Announces Pricing of $450 million Follow-on Public Offering of Common Shares". Tübingen & Boston, MA. |
2021-01-28 |
| High-Tech Gründerfonds Management GmbH. (1/26/21). "Press Release: GeneQuine Biotherapeutics Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases". |
2021-01-26 |
| Microcaps AG. (1/26/21). "Press Release: Microcaps Closes CHF 5 Million Seed Financing Round Co-led by Helvetica Capital and Zürcher Kantonalbank". Zurich. |
2021-01-26 |
| Cellvie Inc.. (1/25/21). "Press Release: Harvard Spin-off Cellvie Closes $5M Seed Round in Pursuit of a New Treatment Modality – Therapeutic Mitochondria Transfer". Zurich & Houston, TX. |
2021-01-25 |
| TScan Therapeutics Inc.. (1/25/21). "Press Release: TScan Therapeutics Announces $100 Million Series C Financing". Waltham, MA. |
2021-01-25 |
| Omnix Medical. (1/25/21). "Press Release: Omnix Medical Wins €10.8M in EIC Accelerator Funding". |
2021-01-25 |
| CureVac N.V.. (1/25/21). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. |
2021-01-25 |
| Merus N.V.. (1/21/21). "Press Release: Merus Announces Pricing of Public Offering of Common Shares". Utrecht & Cambridge, MA. |
2021-01-21 |
| Relief Therapeutics Holding AG. (1/20/21). "Press Release: Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil". Geneva & Gundelfingen. |
2021-01-20 |
| Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. |
2021-01-20 |
| Biophytis S.A.. (1/20/21). "Press Release: Biophytis Announces Public Filing of a Registration Statement for Proposed Initial Public Offering in the United States". Paris & Cambridge, MA. |
2021-01-20 |
| Slate Bio, Inc.. (1/19/21). "Press Release: Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies". Charlottesville, VA. |
2021-01-19 |
| Merus N.V.. (1/19/21). "Press Release: Merus N.V. Announces Proposed Public Offering of Common Shares". Utrecht & Cambridge, MA. |
2021-01-19 |
| Forbion Capital Partners. (1/19/21). "Press Release: Forbion Invests USD 2.3M in Seed Financing of CoviCept Therapeutics, Inc.". Naarden. |
2021-01-19 |
| High-Tech Gründerfonds Management GmbH. (1/18/21). "Press Release: LignoPure Secures € 2.2 Million Seed Round with High-Tech Gründerfonds, Innovationsstarter Fonds Hamburg GmbH (IFH) and Swiss Holding Tanovis AG". |
2021-01-18 |
| Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon. |
2021-01-15 |
| Affimed N.V.. (1/15/21). "Press Release: Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. |
2021-01-15 |
| Cognate Bioservices, Inc.. (1/14/21). "Press Release: Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe". Memphis, TN. |
2021-01-14 |
| NewAmsterdam Pharma B.V.. (1/14/21). "Press Release: NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program". Naarden. |
2021-01-14 |
| UCB S.A.. (1/13/21). "Press Release: UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsy". Brussels & Atlanta, GA. |
2021-01-13 |
| IO Biotech ApS. (1/13/21). "Press Release: IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology". Copenhagen. |
2021-01-13 |
| Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares". Heidelberg. |
2021-01-12 |
| AltPep Corproration. (1/12/21). "Press Release: AltPep Corporation Closes Series A Financing". Seattle, WA. |
2021-01-12 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
